147 related articles for article (PubMed ID: 30834079)
1. Evaluation of synergistic therapeutic effect of shark cartilage extract with artemisinin and glucantime on visceral leishmaniasis in BALB/c mice.
Molaie S; Ghaffarifar F; Dalimi A; Zuhair MH; Sharifi Z
Iran J Basic Med Sci; 2019 Feb; 22(2):146-153. PubMed ID: 30834079
[TBL] [Abstract][Full Text] [Related]
2. Enhancement Effect of Shark Cartilage Extract on Treatment of
Molaie S; Ghaffarifar F; Hasan ZM; Dalimi A
Iran J Pharm Res; 2019; 18(2):887-902. PubMed ID: 31531071
[TBL] [Abstract][Full Text] [Related]
3. Fe3O4@Bio-MOF Nanoparticles Combined with Artemisinin, Glucantime®, or Shark Cartilage Extract on Iranian Strain of
Ghafarifar F; Molaie S; Abazari R; Hasan ZM; Foroutan M
Iran J Parasitol; 2020; 15(4):537-548. PubMed ID: 33884011
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Apoptotic and Antileishmanial Activities of Artemisinin on Promastigotes and BALB/C Mice Infected with Leishmania major.
Ghaffarifar F; Esavand Heydari F; Dalimi A; Hassan ZM; Delavari M; Mikaeiloo H
Iran J Parasitol; 2015; 10(2):258-67. PubMed ID: 26246824
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of artemisinin-loaded nanoparticles in experimental visceral leishmaniasis.
Want MY; Islamuddin M; Chouhan G; Ozbak HA; Hemeg HA; Dasgupta AK; Chattopadhyay AP; Afrin F
Colloids Surf B Biointerfaces; 2015 Jun; 130():215-21. PubMed ID: 25936561
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of
Kaur R; Kaur S
J Tradit Complement Med; 2018 Jan; 8(1):251-260. PubMed ID: 29322016
[TBL] [Abstract][Full Text] [Related]
7. Leishmanicidal potentials of
Sharifi F; Sharififar F; Pournamdari M; Ansari M; Tavakoli Oliaee R; Bamorovat M; Khosravi A; Keyhani AR; Salarkia E; Mortazaeizdeh A; Dabiri S; Khamesipour A; Sharifi I
J Med Microbiol; 2021 Jun; 70(6):. PubMed ID: 34115583
[No Abstract] [Full Text] [Related]
8. Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis.
Bhattacharjee A; Majumder S; Majumdar SB; Choudhuri SK; Roy S; Majumdar S
Int J Antimicrob Agents; 2015 Mar; 45(3):268-77. PubMed ID: 25600891
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Meglumine Antimoniate in a Low Polymerization State Orally Administered in a Murine Model of Visceral Leishmaniasis.
Kato KC; de Morais-Teixeira E; Islam A; Leite MF; Demicheli C; de Castro WV; Corrêa-Junior JD; Rabello A; Frézard F
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866873
[TBL] [Abstract][Full Text] [Related]
10. The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.
Rostan O; Gangneux JP; Piquet-Pellorce C; Manuel C; McKenzie AN; Guiguen C; Samson M; Robert-Gangneux F
mBio; 2013 Sep; 4(5):e00383-13. PubMed ID: 24045639
[TBL] [Abstract][Full Text] [Related]
11. Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system.
Duarte MC; Lage LM; Lage DP; Martins VT; Carvalho AM; Roatt BM; Menezes-Souza D; Tavares CA; Alves RJ; Barichello JM; Coelho EA
Parasitol Int; 2016 Dec; 65(6 Pt A):728-736. PubMed ID: 27425599
[TBL] [Abstract][Full Text] [Related]
12. Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice.
Solgi G; Kariminia A; Abdi K; Darabi M; Ghareghozloo B
Korean J Parasitol; 2006 Mar; 44(1):55-61. PubMed ID: 16514283
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of artemisinin in experimental visceral leishmaniasis.
Sen R; Ganguly S; Saha P; Chatterjee M
Int J Antimicrob Agents; 2010 Jul; 36(1):43-9. PubMed ID: 20403680
[TBL] [Abstract][Full Text] [Related]
14. Garlic induces a shift in cytokine pattern in Leishmania major-infected BALB/c mice.
Ghazanfari T; Hassan ZM; Ebtekar M; Ahmadiani A; Naderi G; Azar A
Scand J Immunol; 2000 Nov; 52(5):491-5. PubMed ID: 11119248
[TBL] [Abstract][Full Text] [Related]
15. Effects of combined therapy with silymarin and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice.
Jabini R; Jaafari MR; Vahdati Hasani F; Ghazizadeh F; Khamesipour A; Karimi G
Drug Res (Stuttg); 2015 Mar; 65(3):119-24. PubMed ID: 24623031
[TBL] [Abstract][Full Text] [Related]
16. Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis.
Want MY; Islammudin M; Chouhan G; Ozbak HA; Hemeg HA; Chattopadhyay AP; Afrin F
Int J Nanomedicine; 2017; 12():2189-2204. PubMed ID: 28356736
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice.
Nilforoushzadeh MA; Shirani-Bidabadi L; Zolfaghari-Baghbaderani A; Saberi S; Siadat AH; Mahmoudi M
J Vector Borne Dis; 2008 Dec; 45(4):301-6. PubMed ID: 19248657
[TBL] [Abstract][Full Text] [Related]
18. Potential application of nanochitosan film as a therapeutic agent against cutaneous leishmaniasis caused by L. major.
Bahrami S; Esmaeilzadeh S; Zarei M; Ahmadi F
Parasitol Res; 2015 Dec; 114(12):4617-24. PubMed ID: 26346452
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B.
Asad M; Bhattacharya P; Banerjee A; Ali N
BMC Infect Dis; 2015 Apr; 15():188. PubMed ID: 25884796
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic effect of ozonated olive oil plus glucantime on human cutaneous leishmaniasis.
Aghaei M; Aghaei S; Sokhanvari F; Ansari N; Hosseini SM; Mohaghegh MA; Hejazi SH
Iran J Basic Med Sci; 2019 Jan; 22(1):25-30. PubMed ID: 30944704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
